Sagespring Wealth Partners, LLC Bristol Myers Squibb CO Transaction History
Sagespring Wealth Partners, LLC
- $3.96 Trillion
- Q1 2025
A detailed history of Sagespring Wealth Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sagespring Wealth Partners, LLC holds 21,578 shares of BMY stock, worth $1.01 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
21,578
Previous 15,768
36.85%
Holding current value
$1.01 Million
Previous $892 Million
47.56%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,810Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.98 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.44 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.07 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.45 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.8B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...